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Serial seizures occur commonly in inpatient epileptic children. This type of 
seizure due to its characteristics has a significant impact on the patient’s health. 
Untreated serial seizures lead to status epilepticus; therefore, finding a more 
effective treatment for such patients is essential. This study was performed to 
compare the outcome of intermittent intravenous diazepam in the pediatric 
neurology clinic and intravenous midazolam in the pediatric intensive care unit 
(PICU), in order to introduce an alternative treatment for serial seizures.
Materials & Methods
In this study, 38 inpatient children aged 6 mo-15 years with refractory serial 
seizures were treated by first line antiepileptic drugs and then randomly 
treated with either intermittent intravenous diazepam in the neurology ward or 
intravenous midazolam in PICU.
Results
Fourteen (70%) diazepam group patients and 13 (72.2%) midazolam group 
patients had good response to treatment, there was no significant difference 
between the two groups. Four midazolam group patients and two diazepam 
group patients needed mechanical ventilation and were intubated during 
treatment, with no significant difference between the two groups. Durations 
of mechanical ventilation and PICU and hospital stay were not significantly 
different between the two groups. 
Conclusion
Intermittent intravenous diazepam is an effective alternative therapy for 
midazolam drip in the treatment of serial seizures due to similar therapeutic 
effects and fewer side effects.
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Introduction
Serial seizures, also known as repetitive or cluster seizures, occur commonly in 
children with epilepsy (1). At the simplest level, serial seizures have been defined as 
the number of seizures per unit time with an increased frequency over the patient’s 
typical seizure (1).
There have been several definitions for serial seizures clinically and statistically 
according to different studies. In studies with a clinical definition for serial seizures, 
cluster patterns have been defined differently; including two to four seizures in a 
short period of ≤48 hours (2); three or more seizures within 24 hours (3, 4); two 
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generalized tonic-clonic or three complex partial seizures 
in 4 hours (5); and a three-fold or four-fold increase over 
usual seizure frequency within a three-day period (6, 
7). From the statistical point of view, serial seizures are 
those without random distribution, or with a dependence 
pattern of interseizure interval (1). Some studies have 
applied Poisson distribution test to seizure frequency, to 
evaluate the randomness of seizures (8, 9).
The prevalence of clustering varies widely between 
studies because there is no definitive clinical definition 
for serial seizures. Whether clinically or statistically 
defined, the prevalence of serial seizures ranges from 
very low up to 60 % (1).
Various studies have suggested risk factors for serial 
seizures, such as epilepsy localization, particularly 
frontal lobe epilepsy; head trauma and a history of 
intractable epilepsy (1).
Serial seizures although not as life threatening as status 
epilepticus, have a significant effect on the patient’s 
health (10) and if left untreated, have been reported to 
progress into status epilepticus (11, 12) indicating a poor 
prognosis of epilepsy (1). The socioeconomic effects of 
serial seizures include missed school days, as well as 
increased consumption of health care resources.
In most hospitals, the first approach as the routine 
approach for refractory serial seizure is admission of 
the patient in the Pediatric Intensive Care Unit (PICU) 
and starting intravenous midazolam infusion. Limited 
PICU services in some remote hospitals were the main 
drawback of this approach. In addition, infusion of 
midazolam drip cannot be administered in the pediatric 
neurology ward. Therefore, treatment of refractory serial 
seizures sometimes becomes a challenging problem.
The aim of this study was achievement of a new method 
for treatment of patients with serial seizures when 
transfer to the PICU is not possible.
Materials & Methods
This study included all admitted children with refractory 
serial seizures in Mofid hospital, which is a referral 
center for pediatric neurological diseases, aged from 6 
months to 15 years, from October 2008 to May 2010.
The diagnostic criteria for refractory serial seizures in 
this study was defined as four generalized tonic-clonic 
or complex partial seizures per day with a three-fold 
increase over usual seizure frequency within a two-day 
period that received at least two appropriate intravenous, 
intramuscular or oral antiepileptic drugs with no decrease 
to less than the pretreatment level in seizure frequency.
Occurrence of status epilepticus due to convulsive 
seizure longer than 30 minutes was considered as 
exclusion criteria, in addition to critical diseases such as 
meningitis and intracranial hemorrhage. 
Patients were randomly assigned to midazolam or 
diazepam groups. The patients were transferred to 
PICU and in the midazolam group, midazolam was 
administered as an intravenous bolus dose (0.2mg/kg), 
followed by continuous intravenous infusion (1-10 μg/
kg per min) and in the diazepam group, intravenous 
diazepam was administered every 3 hours (0.2 mg /kg). 
Decreased seizure frequencies to less than half of 
pretreatment level or complete seizure disappearance 
(for at least 48 hours after discontinuation of these 
drugs) were considered as effective treatment. Decrease 
in seizure frequency, but not less than the pretreatment 
level, was considered as partial response and finally no 
difference was assumed as not effective.
All children were monitored for the development of side 
effects of midazolam and diazepam, such as hypotension 
and respiratory depression. Routine laboratory 
examinations and EEG were performed in all patients. 
Brain CT or MRI was performed if needed.
Data including age, sex, seizure history, underlying 
etiology and outcome were carefully recorded for each 
patient. We compared the two groups by independent 
sample t test, Fisher’s exact test or Mann-Whitney U 
test. A value of P<0.05 was regarded as significant.
This study has been approved by the ethics committee 
of Shahid Beheshti University of Medical Sciences, 
Tehran, Iran.
Results
Overall, 44 children were eligible for our study. We 
excluded six children owing to early death before 
treatment (one patient), transport to other hospitals (one 
patient) and critical situation other than seizure (four 
patients).
Finally, 38 patients, 18 boys and 20 girls (range, 6 months 
to 15 years) were recruited as refractory serial seizures 
(RSS) in this study, 18 patients in the midazolam and 20 
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The safety and efficacy of midazolam has been shown 
by several clinical studies in the treatment of acute 
seizures and status epilepticus in adult and children (15-
18). Midazolam has also successfully controlled serial 
seizures in children (19). The current study showed that 
not only the adverse effects of diazepam were not more 
than midazolam, but also the duration of admission in 
PICU in the midazolam group were longer than the 
diazepam group.
Hayashi et al (18) detected that 20% of the patients 
with status epilepticus treated with midazolam drip 
had respiratory suppuration and needed mechanical 
ventilation. This rate in our study was 22.2%, but our 
patients were clinically different. In that study, 64.5% 
of the status epilepticus patients had good responses to 
midazolam drip compared to the 66.6% rate in our study.
Early termination of serial seizures is important to 
prevent adverse consequences and to reduce the risk of 
development of status epilepticus.
In conclusion, our study showed that intermittent 
intravenous diazepam may be considered as an effective 
alternative therapy for midazolam in the treatment of 
serial seizures, because of similar therapeutic effects and 
less side effects.
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in the diazepam group.
Variables such as sex, age, seizure onset age, 
neurodevelopmental disability and seizure type were not 
significantly different between the two groups (Table 1).
Before admission, six children were treated with one, 
19 with two and others with three antiepileptic drugs. 
Fourteen children (36.8%) had a definite etiology for 
seizure.
In the midazolam group, 13 children (72.2 %) had 
response (12 complete and one partial) to treatment. In 
the diazepam group 14 (70.0 %) children had response 
(10 complete and four partial) to treatment (P = 0.373). 
In patients with good response, the duration of seizure 
control was 17.21 ±22.506 hours in the midazolam 
group and 11.60 ±15.579 hours in the diazepam group.
During hospital admission, four of the midazolam group 
patients and two of the diazepam group patients were 
intubated and needed mechanical ventilation, which 
showed no significant difference between the two 
groups (P= 0.302). Respiratory suppression was related 
to these drugs in four of the midazolam group and two 
of the diazepam group patients, after ruling out other 
conditions such as respiratory infection by a normal 
chest X-ray and a normal laboratory exam. Bradycardia 
was seen in one child under treatment with midazolam, 
but not in the diazepam group.
Duration of stay in PICU and mechanical ventilation 
in the group treated with midazolam was longer than 
the group treated with diazepam, with no significant 
difference between the two groups (Table 2).
In both groups, all patients were discharged and no 
mortality occurred during treatment.
Discussion
To the best of our knowledge, no controlled studies 
have compared the efficacy of intermittent intravenous 
diazepam with intravenous midazolam drip for the 
management of serial seizures. We found that intermittent 
diazepam given intravenously is as safe and effective as 
midazolam drip given intravenously in the management 
of refractory serial seizures in children.
Some investigators have reported the efficacy of rectal 
diazepam in serial seizures (13, 14). Dreifuss et al (13) 
reported an efficacy of rectal diazepam comparable to 
that obtained with placebo in serial seizures (P< 0.001).
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Table 1. Comparative Baseline Characteristics of the Two Groups of Children
Midazolam Diazepam P Value
Chronologic age (mo) 48.78 ± 38.516 71.05 ± 54.401 o.081
Age of onset of first seizure (mo) 19.72 ± 22.932 28.15 ± 43.274 0.274
Gender (Male/Female) 0.80 1.00 0.732
Neurodevelopment disability (%) 61.1 45 0.321










Table 2. Duration of Mechanical Ventilation and Hospital and PICU Stays
Midazolam Diazepam P Value
Duration of hospital stay (day) 15.83 ± 14.460 11.10 ± 7.779 0.063
Duration of PICU stay (day) 10.89 ± 9.305 3.20 ± 6.305 0.106
Duration of mechanical ventilation  4.61 ± 7.912 1.35 ± 5.174 0.054
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